FDA approved Vaxelis, a new combination DTaP-IPV-Hib-HepB vaccine for use in children 6 wks-4 yrs of age
On Dec. 26, 2018, Sanofi announced the U.S. Food and Drug Administration (FDA) had approved VAXELIS (Diphtheria and…
On Dec. 26, 2018, Sanofi announced the U.S. Food and Drug Administration (FDA) had approved VAXELIS (Diphtheria and…
On Dec. 20, 2018, the Karmanos Cancer Institute and Wayne State University were awarded the prestigious LAPS Grant…
On Dec. 17, 2018, the Karmanos Morey Cancer Center was recognized by the American Society of Clinical Oncology…
On Dec. 12, 2018, the Allen Institute announced the launch of the Allen Institute for Immunology, a new…
On Dec. 6, 2018, the Horace G. Fralin Charitable Trust and Heywood and Cynthia Fralin donated a record…
On Dec. 5, 2018, Seqirus, a CSL subsidiary, announced real-world data showing that its cell-based quadrivalent influenza vaccine…
On Dec. 5, 2018, Genomics England announced the 100,000 Genomes Project, done in partnership with National Health Service…
On Dec 3, 2018, a University of California, Los Angeles (UCLA) led research team announced they had identified…
On Nov. 30, 2018, Sean Norman, associate professor of environmental health sciences and director of the Molecular Microbial…
On Nov. 29, 2018, St. Louis native Rodger Riney and his wife, Paula, donated $20 million to research…
On Nov. 28, 2018, The U.S. Food and Drug Administration (FDA) announced it had approved the first ever…
On Nov. 27, 2018, the Canadian Cancer Trials Group, a new clinical trial, opened across Canada. This was…
On Nov. 20, 2018, the Abramson Cancer Center joined the National Comprehensive Cancer Networkᆴ (NCCN) as its 28th…
On Nov. 13, 2018, Canadian Prime Minister Justin Trudeau announced federal funding for the Institute for Advanced Medical…
On Nov. 13, 2018, the Mayo Clinic announced a gift of $200 million from Jay Alix, noted philanthropist…
On Nov. 5, 2018, Pascal Biosciences announced the peer reviewed publication of their licensed cannabinoid-derived drug program for…
On Nov. 2, 2018, the Immunization Practices Advisory Committee (ACIP) Hepatitis Vaccines Work Group conducted a systematic review…
On Nov. 2, 2018, the U.S. Food and Drug Administration announced they had approved AcelRx Pharmaceuticals Inc’s opioid-based…
On Nov. 1, 2018, City of Hope, and its affiliate, Translational Genomics Research Institute (TGen), announced a letter…
On Nov. 1, 2018, the Earth BioGenome Project (EBP) was launched, a global effort to sequence the genetic…
On Oct. 30, 2018, Pascal Biosciences announced the Company had entered into an exclusive license agreement with the…
On Oct. 29, 2018, Archaeological evidence of cacao’s use, dating back to 3,900 years ago, previously planted the…
On Oct. 25, 2018, The Foundation for the National Institutes of Health, Biomarkers Consortium and the Critical Path…
On Oct. 25, 2018, the American Dental Association announced it had adopted a policy that urges dentists to…
On Oct. 24, 2018, the U.S. Food and Drug Administration (FDA) approved XOFLUZA™ (baloxavir marboxil) for the treatment…
On Oct. 22, 2018, the Siteman Cancer Center announced it will open its second proton therapy unit on…
On Oct. 22, 2018, the National Cancer Institute (NC) awarded a $10.7 million five year grant to Abramson…
On Oct. 18, 2018, an international team of researchers reported that a surge in Lassa fever cases in…
On Oct. 16, 2018, Conversant Bio, Folio Bio, Discovery Life Sciences and Phylogeny announced that they have merged…
On Nov. 9, 2918, the U.S. Centers for Disease Control and Prevention (CDC) reported an estimated 47.4 million…